Published in Chirurg on June 01, 2003
Strategies to optimize the use of marginal donors in liver transplantation. World J Hepatol (2015) 0.95
Dynamical changing patterns of glycogen and enzyme histochemical activities in rat liver graft undergoing warm ischemia injury. World J Gastroenterol (2005) 0.86
Safe time to warm ischemia and posttransplant survival of liver graft from non-heart-beating donors. World J Gastroenterol (2004) 0.79
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet (2001) 3.62
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology (1990) 3.03
Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterology (1990) 2.64
Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun (2001) 2.30
Structure of the Abelson murine leukemia virus genome. Cell (1979) 2.27
Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology (1995) 2.21
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet (2000) 2.01
Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infect Immun (1990) 1.88
TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol (1999) 1.69
Autoimmunity and liver disease. Hepatology (1990) 1.65
Transmission of Helicobacter spp. A challenge to the dogma of faecal-oral spread. Epidemiol Infect (1991) 1.58
Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. Gastroenterology (1993) 1.58
Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology (1999) 1.54
Helicobacter felis gastritis in gnotobiotic rats: an animal model of Helicobacter pylori gastritis. Infect Immun (1991) 1.51
Identification and propagation of a putative immunosuppressive orphan parvovirus in cloned T cells. J Immunol (1993) 1.49
Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo). Infect Immun (1991) 1.46
Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology (1998) 1.46
A new treatment for severe malabsorption due to radiation enteritis. Lancet (1996) 1.45
Autoimmune hepatitis. N Engl J Med (1995) 1.45
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med (1998) 1.42
Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa. Kidney Int (2007) 1.37
Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens. J Immunol Methods (1996) 1.33
Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis. Oncogene (2001) 1.33
IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol (1998) 1.32
Mouse models of liver fibrosis. Z Gastroenterol (2007) 1.29
Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology (1990) 1.25
Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol (1995) 1.24
Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease. Endoscopy (2003) 1.24
Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat (2001) 1.23
Gastric colonization of the ferret with Helicobacter species: natural and experimental infections. Rev Infect Dis (1991) 1.19
Synovial fluid-derived Yersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells. Eur J Immunol (1991) 1.17
Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut (2002) 1.16
Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol (1996) 1.16
Role of Helicobacter felis in chronic canine gastritis. Vet Pathol (1992) 1.15
Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol (1999) 1.13
Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol (2001) 1.12
Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology (1996) 1.12
Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch (1997) 1.10
Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes (1994) 1.10
Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol (2007) 1.07
p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene (1994) 1.06
Structure and expression of the Abelson murine leukemia virus genome and its relationship to a normal cell gene. Cold Spring Harb Symp Quant Biol (1980) 1.05
Uncoupling of XB/U-cadherin-catenin complex formation from its function in cell-cell adhesion. J Biol Chem (1997) 1.04
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol (1999) 1.04
Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology (1996) 1.04
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy. Oncol Rep (2006) 1.04
Cadherin transfection of Xenopus XTC cells downregulates expression of substrate adhesion molecules. Mol Cell Biol (1995) 1.04
Hypertension and hyperlipidaemia: garlic helps in mild cases. Br J Clin Pract Suppl (1990) 1.02
Preservation damage in liver transplantation. Influence of rapid cooling. Transplantation (1986) 1.00
Duration of immunosuppressive therapy in autoimmune hepatitis. J Hepatol (2001) 0.99
A bioinformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas. Hepatology (2001) 0.99
Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol (1991) 0.99
Image reconstruction with acoustic measurement using distorted Born iteration method. Ultrason Imaging (1996) 0.98
Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur J Clin Invest (2000) 0.97
Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver. Hepatology (1997) 0.97
Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery. Hum Mol Genet (1994) 0.96
Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol (2008) 0.95
Preservation damage in liver transplantation: electron-microscopic findings. Transplant Proc (1984) 0.95
Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch (1997) 0.94
Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J Hepatol (1998) 0.94
Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis. Liver (1996) 0.93
Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. J Infect Dis (1998) 0.93
[Autoimmune liver diseases]. Internist (Berl) (2009) 0.92
[Diagnosis of and therapy for hepatocellular carcinoma]. Z Gastroenterol (2013) 0.91
The role of autoimmunity in hepatitis C infection. J Hepatol (1995) 0.91
Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Arch (1999) 0.91
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. Am J Transplant (2007) 0.91
Autoimmune hepatitis in the elderly. Am J Gastroenterol (2001) 0.91
Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation. Transplantation (1996) 0.91
Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies. J Autoimmun (2001) 0.90
Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol (1997) 0.90
Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience. Eur J Surg Oncol (2013) 0.90
Therapeutic modalities and prognostic factors for primary and secondary liver tumors. World J Surg (1995) 0.90
Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics (1997) 0.89
Proliferative response of synovial fluid and peripheral blood mononuclear cells to arthritogenic and non-arthritogenic microbial antigens and to the 65-kDa mycobacterial heat-shock protein. Med Microbiol Immunol (1990) 0.89
[Liver transplantation in the GDR]. Khirurgiia (Mosk) (1981) 0.88
Adalimumab could suppress the activity of non alcoholic steatohepatitis (NASH). Z Gastroenterol (2008) 0.88
Bone disease after liver transplantation. Transplant Proc (1992) 0.88
N-acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantation. Transplantation (2001) 0.88
Stimulation of synovial fluid mononuclear cells with the human 65-kD heat shock protein or with live enterobacteria leads to preferential expansion of TCR-gamma delta+ lymphocytes. Clin Exp Immunol (1992) 0.88
Clinical modeling of T cell vaccination against autoimmune diseases in rats. Selection of antigen-specific T cells using a mitogen. J Clin Invest (1990) 0.88
Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases. Z Gastroenterol (1997) 0.88
In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model. Antimicrob Agents Chemother (2011) 0.87
Biliary tract strictures after orthotopic liver transplantation: diagnosis and management. Endoscopy (1994) 0.87
Successful treatment of complete inferior vena cava thrombosis after liver transplantation by thrombolytic therapy. Br J Surg (1992) 0.87
Improvement of hepatic microhemodynamics by N-acetylcysteine after warm ischemia. Eur Surg Res (1996) 0.87
Liver transplantation for hepatocellular carcinoma--is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res (2011) 0.87
Fatal hepatic necrosis after isoflurane anaesthesia. Anaesthesia (1997) 0.86
The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transpl Int (1998) 0.86
Minilaparoscopy-guided spleen biopsy in systemic disease with splenomegaly of unknown origin. Endoscopy (2002) 0.86
Multiplex neuritis in a patient with autoimmune hepatitis: a case report. World J Gastroenterol (2006) 0.86
Analysis of extravascular endothelin levels in UW solution and rinsing effluent of porcine liver grafts after cold storage. Transplant Proc (1995) 0.86